As of June 2024 InnovAge has a market cap of $0.69 Billion. This makes InnovAge the world's 5609th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.69 B | -15.27% |
2023 | $0.81 B | -16.24% |
2022 | $0.97 B | 43.66% |
2021 | $0.67 B |
On Jun 15th, 2024 the market cap of InnovAge was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Merck MRK | $327.94 B | 47,372.38% | ๐บ๐ธ USA |
![]() Cocrystal Pharma
COCP | $24.31 M | -96.48% | ๐บ๐ธ USA |
![]() AcelRx Pharmaceuticals
ACRX | $14.57 M | -97.89% | ๐บ๐ธ USA |
![]() Horizon Therapeutics
HZNP | $26.63 B | 3,755.15% | ๐ฎ๐ช Ireland |